title: Beta-blockers and reverse remodeling: what are the implications?
authors.forename: Gary S
authors.initials: GS
authors.lastname: Francis
authors.forename: W H Wilson
authors.initials: WH
authors.lastname: Tang
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D002311:Cardiomyopathy, Dilated / Q000188:drug therapy / Q000503:physiopathology; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D013318:Stroke Volume / Q000187:drug effects / Q000502:physiology; D016896:Treatment Outcome; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy / Q000503:physiopathology; D020257:Ventricular Remodeling
chemical_list: D000319:Adrenergic beta-Antagonists